as on September 16, 2025 at 7:42 pm IST
Day's Low
Day's High
1.37%
Downside
0.62%
Upside
52 Week's Low
52 Week's High
43.63%
Downside
10.49%
Upside
Check Zymeworks Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-0.7826
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.51
Industry PE ratio
-0.49107142857142855
P/B Ratio
0PEG Ratio
0EBITDA
-72.6M
Revenue (TTM)
122.9M
Profit Margin
-59.96%
Return On Equity TTM
41853100.00%
Track how Zymeworks Inc P/E has moved over time to understand its valuation trends.
Zymeworks Inc in the last 5 years
Lowest (2.37x)
September 30, 2023
Today (-3.51x)
September 16, 2025
Industry (-0.49x)
September 16, 2025
Highest (3.97x)
December 31, 2022
Today’s Price to Earnings Ratio: -3.51x
Compare market cap, revenue, PE, and other key metrics of Zymeworks Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.2B | NA | -3.51 | -59.96% | |
BUY | $61.1B | 251.26% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.2B | 47.46% | 28.09 | 31.86% | |
BUY | $59.6B | 0.6% | 14.1 | 31.37% |
The Zymeworks Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Zymeworks Inc investment value today
Current value as on today
₹1,32,925
Returns
₹32,925
(+32.93%)
Returns from Zymeworks Inc Stock
₹28,058 (+28.06%)
Dollar Returns*
₹4,867 (+4.87%)
Based on 14 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Zymeworks Inc. Average target price of $21.05
Get share price movements and forecasts by analysts on Zymeworks Inc.
What analysts predicted
23.9%UPSIDE
Target Price
$21.05
Current Price
$16.02
Analyzed by
14 Analysts
Target
$21.05
Zymeworks Inc target price $21.05, a slight upside of 23.9% compared to current price of $16.02. According to 14 analysts rating.
Search interest for Zymeworks Inc Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 27.11M → 48.72M (in $), with an average increase of 44.4% per quarter
Profit Spike
Netprofit is up for the last 5 quarters, -37.68M → 2.31M (in $), with an average increase of 283.5% per quarter
Best in 3 Years
In the last 3 years, ZYME has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 3 years, ZYME stock has moved up by 181.4%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 43.3%
Organisation | Zymeworks Inc |
Headquarters | 108 Patriot Drive, Middletown, DE, United States, 19709 |
Industry | Health Technology |
CEO | Mr. Kenneth H. Galbraith C.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Leone D. Patterson CPA, M.B.A. | Executive VP and Chief Business & Financial Officer |
Dr. Paul A. Moore Ph.D. | Chief Scientific Officer |
Mr. Mark Hollywood | Executive VP and Head of Technical & Manufacturing Operations |
Mr. Daniel Dex J.D., Ph.D. | Senior VP, Corporate Secretary & General Counsel |
Ms. Laura O'Connor | Vice President of Human Resources & DEI |
Mr. Kenneth H. Galbraith C.A. | Chairman of the Board, CEO & President |
Ms. Shrinal Inamdar | Director of Investor Relations |
Diana Papove | Senior Manager of Corporate Communications |
Dr. Lindsey Foulkes B.Sc., Ph.D. | Vice President of Corporate Development |
Dr. Jeffrey Smith M.D. | Executive VP & Chief Medical Officer |
Zymeworks Inc share price today is $16.02 as on . Zymeworks Inc share today touched a day high of $16.12 and a low of $15.8.
Zymeworks Inc share touched a 52 week high of $17.7 on and a 52 week low of $9.03 on . Zymeworks Inc stock price today i.e. is trending at $16.02,which is 9.49% down from its 52 week high and 77.41% up from its 52 week low.
Zymeworks Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Zymeworks Inc (ZYME) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Zymeworks Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Zymeworks Inc share’s latest price of $16.02 as on September 16, 2025 at 7:42 pm IST, you will get 0.6242 shares of Zymeworks Inc. Learn more about
fractional shares .